ActiveGRANT

DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award

Name: DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Creator: Department of Defense
Keywords: GRANT

Department of DefenseDefense Health Agency Contracting Activity - DHACA

AI Overview

Accelerate translational research in Duchenne muscular dystrophy toward clinical applications. DoD supports advanced preclinical and clinical studies with flexible funding levels and partnership options to bridge promising discoveries into therapies.

This summary is AI-generated from the official solicitation.

Key Details

Agency

Department of Defense

Funding Amount

—

Release Date

June 17, 2026

Due Date

September 18, 2026

Official Description

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. <st...

View on official source

Change History

Field UpdatedJun 24, 2026 at 9:04 PM